Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia

被引：10
|
作者：
Kurosawa, Motohiro [1 ]
机构：
[1] Sutoh Hosp, Dept Allergy & Resp Med, 3532-5 Annaka, Gunma 3790116, Japan
来源：
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2020年 / 30卷 / 02期
关键词：
Benralizumab; Chronic eosinophilic pneumonia; Anti-interleukin; 5; antibody; Mepolizumab;
D O I：
10.18176/jiaci.0468
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [11] Anti-interleukin 5 treatment in moderate to severe eosinophilic chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Rosellen Tan, Irene
    Elvi Villalobos, Ralph
    May Jaen, Anjuli
    David-Wang, Aileen
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [12] Development of Rheumatoid Arthritis During Anti-Interleukin-5 Therapy in a Patient with Refractory Chronic Eosinophilic Pneumonia
    Kawabata, Hiroki
    Satoh, Minoru
    Yatera, Kazuhiro
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 1425 - 1430
  • [13] Anti-interleukin 5 strategies as a potential treatment for asthma
    Singh, AD
    Sanderson, CJ
    THORAX, 1997, 52 (05) : 483 - 485
  • [14] NOVEL USE OF ANTI-INTERLEUKIN-5 THERAPY, MEPOLIZUMAB, IN CHRONIC EOSINOPHILIC PNEUMONIA
    Lam, W.
    Ramsey, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S68 - S68
  • [15] ANTI-INTERLEUKIN 5 THERAPY FOR REFRACTORY EOSINOPHILIC GRANULOMATOSIS WITH POLYANGITIS AND HYPEREOSINOPHILIC SYNDROME OVERLAP
    McKernan, A.
    Wild, L.
    Le, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S119 - S119
  • [16] CHRONIC EOSINOPHILIC PNEUMONIA - A LONG-TERM FOLLOW-UP OF 12 PATIENTS
    NAUGHTON, M
    FAHY, J
    FITZGERALD, MX
    CHEST, 1993, 103 (01) : 162 - 165
  • [17] Long-term follow-up of pulmonary function in chronic eosinophilic pneumonia
    Durieu, J
    Wallaert, B
    Tonnel, AB
    Bart, F
    Beaujot, S
    Benard, A
    Bervar, JF
    Broux, J
    Cardot, E
    Chevalon, B
    Dansin, E
    Degive, P
    Delaunois, L
    Delepoulle, E
    Demarcq, G
    Deroubaix, C
    Duthoit, A
    Florin, M
    Ficheroulle, X
    Fortin, F
    Fourquet, B
    Grignet, JP
    Grosbois, JM
    Gustin, M
    Herengt, F
    Lafitte, JJ
    Lierman, Y
    Marquette, CH
    Maetz, E
    Mellin, B
    Monnot, H
    Pagnier, F
    Perez, T
    Rademacker, E
    Ramon, P
    Roux, JP
    Stach, B
    Steenhouwer, F
    Soots, J
    Tack, V
    TillieLeblond, I
    Tulippe, C
    VanParys, C
    Varlet, F
    Wallaert, C
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (02) : 286 - 291
  • [18] Anti-interleukin 5 strategies as a potential treatment for asthma - Commentary
    Walker, WS
    THORAX, 1997, 52 (05) : 486 - 486
  • [19] Influence of anti-interleukin (IL)-5/anti-IL-5 receptor-α treatment on work productivity in patients with severe eosinophilic asthma
    Drick, Nora
    Brinkmann, Lina
    Fuge, Jan
    Welte, Tobias
    Suhling, Hendrik
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [20] Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing
    Prieto-Garcia, Alicia
    Peligros, Maria Isabel
    Tamayo, Isabel Perez
    Zubeldia, Jose Manuel
    Alvarez-Sala, Luis
    Lavilla, Cristina
    JOURNAL OF ASTHMA, 2024, 61 (01) : 69 - 71
12345